El-ASSAL, MONA IBRAHIM, and DALIA SAMUEL. 2022. “OPTIMIZATION OF RIVASTIGMINE CHITOSAN NANOPARTICLES FOR NEURODEGENERATIVE ALZHEIMER; IN VITRO AND EX VIVO CHARACTERIZATIONS”. International Journal of Pharmacy and Pharmaceutical Sciences 14 (1):17-27. https://doi.org/10.22159/ijpps.2022v14i1.43145.